Can pelvic exercises boost estrogen therapy for bladder control?
NCT ID NCT07186985
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study looks at whether adding pelvic floor muscle training to vaginal estrogen therapy helps postmenopausal women with stress urinary incontinence more than estrogen alone. About 115 women will be randomly assigned to either the combined treatment or estrogen-only group. The goal is to see if the combination reduces urine leakage better over 6 months.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
pelvic floor muscle training and vaginal estrogen therapy
What this could lead to
If successful, this could offer a more effective non-surgical option for managing stress urinary incontinence in postmenopausal women.
What could go wrong
This is a small, early-stage trial with only 115 participants, so results may not apply to all women. The combination therapy may not prove significantly better than estrogen alone.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for STRESS URINARY INCONTINENCE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••